Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.33249 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.32745 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.33156 | 13 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.30246 | 14 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.23819 | 11 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.35396 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.35953 | 13 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.30631 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.31066 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.44522 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.31157 | 13 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.31367 | 14 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.31352 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.31178 | 13 |